Severe Acute Respiratory Syndrome (SARS) is a disease that first appeared in humans in November 2002. Infection initially brings flu-like symptoms including fever and fatigue, but it then attacks ...
Study highlights a fourfold increase in ME/CFS risk among COVID-19 patients, with 89% of post-COVID ME/CFS cases overlapping ...
The majority of working-age patients with postacute sequelae of COVID-19/post-COVID-19 syndrome (PCS) do not recover ...
A recent study finds that the risk for myalgic encephalomyelitis/chronic fatigue syndrome is increased following COVID-19.
InflaRx (NASDAQ:IFRX) has received EU regulatory approval for its treatment Gohibic for the treatment of COVID-19 patients ...